>_ QFI Terminal
TerminalStocks › TMCI

Treace Medical Concepts, Inc. (TMCI) Stock

Healthcare · Medical - Devices · US
$1.97 +28.97%
Last updated Jun 19, 2026 00:00 UTC

TMCI Key Statistics

Market Cap$127.46M
P/E (TTM)-2.10
P/S (TTM)0.60
P/B (TTM)1.44
Revenue (TTM)$212.69M
EPS (TTM)$-0.94
Dividend Yield
ROE (TTM)-62.19%
Net Margin-27.74%
Gross Margin79.81%
52W High$2.20
52W Low$1.17
Analyst ViewHold
Price Target$3.00
Employees477
Volume7,515,661

About Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

CEO: John T. Treace. Company website

See TMCI live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open TMCI in Terminal See plans

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corporation MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.